Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses

Documenti analoghi

• 1982. Multiplex PCR-Based Analysis of Enteric Pathogens in Faecal Samples from Patients with Clostridium difficile Infection in the Randomized, Controlled EXTEND Study Comparing the Efficacy of Extended-Pulsed Fidaxomicin With Vancomycin Therapy
  di: Wilcox, Mark, et al.
  Pubblicazione: (2018)
• 1952. Evaluation of Relapse and Reinfection Using Whole-Genome Sequencing of Clostridium difficile Isolates From Elderly Patients With C. difficile Infection (CDI) in the EXTEND Randomized, Controlled, Comparative Study of Extended-Pulsed Fidaxomicin and Vancomycin for the Treatment of CDI
  di: Wilcox, Mark, et al.
  Pubblicazione: (2018)
• Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Clostridioides difficile Infection in the EXTEND Study
  di: Wilcox, Mark H, et al.
  Pubblicazione: (2019)
• Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness
  di: Cornely, Oliver A, et al.
  Pubblicazione: (2018)
• Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
  di: Cornely, Oliver A., et al.
  Pubblicazione: (2012)